IMMUNITYBIO, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number
IMMUNITYBIO, INC. (IBRX) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number of 14.79 million shares as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber · last filed 2026-08-04
- 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number 14.79M shares.
- 2026-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number 14.15M shares.
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number 9.66M shares.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number 9.70M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number |
|---|---|
| 2026-06-30 | 14.79M shares 10-Q · filed 2026-08-04 |
| 2026-03-31 | 14.15M shares 10-Q · filed 2026-05-07 |
| 2025-12-31 | 9.66M shares 10-Q · filed 2026-08-04 |
| 2025-09-30 | 9.70M shares 10-Q · filed 2025-11-05 |
| 2025-06-30 | 11.18M shares 10-Q · filed 2025-08-05 |
| 2025-03-31 | 11.10M shares 10-Q · filed 2025-05-12 |
| 2024-12-31 | 8.04M shares 10-K · filed 2026-02-23 |
| 2024-09-30 | 8.07M shares 10-Q · filed 2024-11-12 |
| 2024-06-30 | 8.24M shares 10-Q · filed 2024-08-12 |
| 2024-03-31 | 7.44M shares 10-Q · filed 2024-05-09 |
| 2023-12-31 | 5.87M shares 10-K · filed 2025-03-03 |
| 2023-09-30 | 5.88M shares 10-Q · filed 2023-11-09 |
| 2023-06-30 | 5.96M shares 10-Q · filed 2023-08-08 |
| 2023-03-31 | 5.05M shares 10-Q · filed 2023-05-11 |
| 2022-12-31 | 3.45M shares 10-K · filed 2024-03-19 |
| 2022-09-30 | 3.46M shares 10-Q · filed 2022-11-09 |
| 2022-06-30 | 3.46M shares 10-Q · filed 2022-08-08 |
| 2022-03-31 | 3.31M shares 10-Q · filed 2022-05-10 |
| 2021-12-31 | 3.04M shares 10-K · filed 2023-03-01 |
| 2021-09-30 | 3.08M shares 10-Q · filed 2021-11-12 |
| 2020-12-31 | 4.35M shares 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 |